Latest On-Demand Webinars & Online Events

Alzheimer’s disease is the most common form of neurodegenerative disease, estimated to contribute to 60–70% of all cases of dementia worldwide. Increasing evidence suggests that neuroinflammation, primarily mediated by microglia, contributes to the onset and progression of Alzheimer’s disease.

Join us for an extended webinar focusing on the recent advances in psilocybin research.

Our major findings were that the neural network was able to accurately classify 11 out of 12 leukemia samples, with as little as 5 minutes of sequencing needed to accurately classify ALL.

In order to generate a genomic atlas of protein levels in neurologically relevant tissues, Dr. Carlos Cruchaga and his team profiled thousands of proteins, and performed bioinformatic analyses to determine if any of the identified proteins are drugable.

This webinar explores the use of high-resolution ion mobility performed on the MOBIE platform for the characterization of different lipid classes starting from phosphatidylcholines and gangliosides.

Join us on June 22 with Boris Heifets, MD, PhD, Assistant Professor of the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine, who will explore the future of psychedelic medicine.

Kevin McKernan, CSO at Medicinal Genomics will be joining us to discuss genetic variation in the Psilocybe cubensis synthesis pathway and the design of qPCR assays for simultaneous quantification of E. coli and Salmonella species contamination concurrent with Psilocybe cubensis species identification.

This inaugural online symposium will explore the tools and techniques being used to study diseases in the lab. Focus will be given to cell culture, organ-on-a-chip and organoid models, as well as, how innovations are enabling researchers to elucidate the underlying biological mechanisms of disease and support diagnostic and therapeutic development.

In the first part of this webinar, Kirk will talk about headspace sampling and GC-MS measurement of residual solvents using the JEOL JMS-Q1500GC quadrupole GC-MS system, and how the technique can meet California’s minimum reporting limits.

Dr. Nemes will share developments from his lab that enabled the in situ and in vivo measurement of metabolites and proteins in single cells in live tissues and organisms, while Dr. Orsburn will explain how leaps in mass spectrometry can facilitate unprecedented sequence coverage of protein at the single-cell level.